P

Inventor

FLYER ALEC NATHANSON

US10 patents
⚠️ This page may combine multiple inventors who share the name “FLYER ALEC NATHANSON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NOVARTIS AG

4 patents
US11813306B2Nov 14, 2023

Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders

NOVARTIS AG0 citations56
US11026993B2Jun 8, 2021

Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders

NOVARTIS AG0 citations55
US11427586B2Aug 30, 2022

1,2,4-oxadiazole derivatives as liver X receptor agonists

NOVARTIS AG0 citations46
US12209144B2Jan 28, 2025

Cyclic peptides as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders

NOVARTIS AG0 citations43

HARVARD COLLEGE

3 patents
US9127019B2Sep 8, 2015

Cortistatin analogues and synthesis thereof

HARVARD COLLEGE7 citations81
US9714255B2Jul 25, 2017

Cortistatin analogues and syntheses thereof

HARVARD COLLEGE1 citations60
US10202400B2Feb 12, 2019

Cortistatin analogues and syntheses thereof

HARVARD COLLEGE0 citations49

ADAMS CHRISTOPHER MICHAEL

2 patents
US8846656B2Sep 30, 2014

Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulators

ADAMS CHRISTOPHER MICHAEL2 citations59
US9505755B2Nov 29, 2016

Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5A receptor modulators

ADAMS CHRISTOPHER MICHAEL0 citations48

SELUX DIAGNOSTICS INC

1 patent
US10048269B2Aug 14, 2018

Assay methods involving dissociable nanoparticles

SELUX DIAGNOSTICS INC0 citations50